Akums Drugs to host investor meet on Sept 2 in Mumbai

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Akums Drugs will host investors on September 2, 2026
  • The event is part of the Ashwamedh – Elara India Dialogue
  • The physical session will be held at Hyatt, Mumbai
  • No unpublished price-sensitive information will be shared
powered bylight_fuzz_icon
49204063

*this image is generated using AI for illustrative purposes only.

Akums Drugs & Pharmaceuticals will participate in an investor and analysts meet scheduled for September 2, 2026. The event forms part of the Ashwamedh – Elara India Dialogue 2026 series.

The company confirmed the schedule in a disclosure filed with stock exchanges on August 25, 2026. The meet is set for 2:00 pm at the Hyatt in Santacruz East, Mumbai. It will be conducted as a physical group session.

Event Details

Particulars Details
Event Name Ashwamedh – Elara India Dialogue 2026
Date September 2, 2026
Time 2:00 pm
Mode Physical
Location Hyatt, Santacruz East, Mumbai

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Akums stated that no unpublished price-sensitive information would be shared during the session.

Dharamvir Malik, Company Secretary and Compliance Officer, signed the intimation. The company noted that the schedule remains subject to change based on exigencies from either the investors or the firm.

Historical Stock Returns for Akums Drugs & Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-3.28%+0.14%+8.40%+54.03%+55.75%-6.43%

How might Akums Drugs' strategic roadmap presented at the dialogue influence its valuation multiples in the mid-cap pharma sector?

Will the management provide updated guidance on R&D pipeline milestones or new product launches post-September 2026?

How does Akums Drugs plan to address potential regulatory headwinds in key international markets during this investor interaction?

Akums Drugs & Pharma cancels investor meet on August 25 due to medical reasons

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Akums Drugs & Pharma cancels participation in investor meet scheduled for August 25, 2026
  • Cancellation attributed to medical reasons affecting concerned personnel
  • Event was organized by Antique Stock Broking Limited in Mumbai
  • Company notified stock exchanges on August 24, 2026
powered bylight_fuzz_icon
49110641

*this image is generated using AI for illustrative purposes only.

Akums Drugs & Pharmaceuticals Ltd has cancelled its participation in the investor and analysts meet scheduled for August 25, 2026. The company cited medical reasons as the cause for the cancellation.

The event was organized by Antique Stock Broking Limited at Trident in the Bandra Kurla Complex, Mumbai. The company had previously intimated its participation in a filing dated August 13, 2026.

Update Details

Akums Drugs & Pharmaceuticals Limited informed the National Stock Exchange of India Ltd and BSE Limited on August 24, 2026, that concerned personnel would not be able to attend the scheduled meeting. Consequently, the company's participation stands cancelled.

Dharamvir Malik, Company Secretary and Compliance Officer, signed the communication. The registered office of the company is located in New Delhi.

Historical Stock Returns for Akums Drugs & Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-3.28%+0.14%+8.40%+54.03%+55.75%-6.43%

Will Akums Drugs reschedule the investor meet, and if so, what is the expected timeline for the new date?

Could the cited medical reasons indicate broader management health issues that might impact operational continuity?

How will this cancellation affect investor sentiment and the stock's short-term volatility given the missed communication opportunity?

More News on Akums Drugs & Pharma

1 Year Returns:+55.75%